"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LUNG.
| Descriptor ID |
D008175
|
| MeSH Number(s) |
C04.588.894.797.520 C08.381.540 C08.785.520
|
| Concept/Terms |
Lung Neoplasms- Lung Neoplasms
- Pulmonary Neoplasms
- Neoplasms, Lung
- Lung Neoplasm
- Neoplasm, Lung
- Neoplasms, Pulmonary
- Neoplasm, Pulmonary
- Pulmonary Neoplasm
Lung Cancer- Lung Cancer
- Cancer, Lung
- Cancers, Lung
- Lung Cancers
- Pulmonary Cancer
- Cancer, Pulmonary
- Cancers, Pulmonary
- Pulmonary Cancers
- Cancer of the Lung
- Cancer of Lung
|
Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".
This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 10 | 4 | 14 |
| 1997 | 9 | 0 | 9 |
| 1998 | 13 | 1 | 14 |
| 1999 | 7 | 3 | 10 |
| 2000 | 12 | 1 | 13 |
| 2001 | 12 | 5 | 17 |
| 2002 | 23 | 9 | 32 |
| 2003 | 32 | 13 | 45 |
| 2004 | 29 | 8 | 37 |
| 2005 | 35 | 10 | 45 |
| 2006 | 30 | 12 | 42 |
| 2007 | 41 | 10 | 51 |
| 2008 | 44 | 9 | 53 |
| 2009 | 35 | 3 | 38 |
| 2010 | 44 | 4 | 48 |
| 2011 | 54 | 11 | 65 |
| 2012 | 51 | 4 | 55 |
| 2013 | 58 | 6 | 64 |
| 2014 | 53 | 6 | 59 |
| 2015 | 75 | 9 | 84 |
| 2016 | 73 | 11 | 84 |
| 2017 | 63 | 3 | 66 |
| 2018 | 80 | 6 | 86 |
| 2019 | 74 | 8 | 82 |
| 2020 | 79 | 6 | 85 |
| 2021 | 98 | 4 | 102 |
| 2022 | 75 | 0 | 75 |
| 2023 | 75 | 1 | 76 |
| 2024 | 68 | 8 | 76 |
| 2025 | 63 | 4 | 67 |
| 2026 | 44 | 5 | 49 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Stereotactic radiosurgery (SRS) for small cell lung cancer (SCLC) brain metastases: a real-world UK tertiary center experience. Br J Radiol. 2026 Oct 01; 99(1186):2148-2154.
-
Current challenges and emerging therapeutic strategies in lung cancer care: Insights from Bridging the Gaps 2025. Cancer. 2026 Oct 01; 132(19):e70633.
-
SUNRAY-02: a study of olomorasib combined with immunotherapy in stage II-III KRAS G12C-mutant non-small cell lung cancer after definitive therapy. Future Oncol. 2026 Sep; 22(22):2673-2682.
-
Prolonged survival after systemic immune reactivation by aglatimagene besadenovec plus valacyclovir in immune checkpoint inhibitor-refractory non-small cell lung cancer. J Immunother Cancer. 2026 Sep 28; 14(9).
-
Myeloid reprogramming generates myeloid-derived activating cells to potentiate radiotherapy and suppress metastasis. Cancer Cell. 2026 Oct 12; 44(10):2011-2028.e7.
-
Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC. Nat Med. 2026 Sep; 32(9):3235-3247.
-
Early detection of invasive lung cancer and multiorgan metastasis by a collagen-targeted protein MRI contrast agent. Sci Adv. 2026 Sep 11; 12(37):eadz6815.
-
All Together Now: Standardization of Nomenclature for Neuroendocrine Neoplasms across Multiple Organs. Clin Lab Med. 2026 Sep; 46(3):577-606.
-
Pan-tumor spatial transcriptomics reveals conserved properties of tumor organization. Cell Rep Med. 2026 Sep 15; 7(9):103013.
-
Crizotinib versus observation or placebo for surgically resected early-stage ALK-positive non-small-cell lung cancer (Eastern Cooperative Oncology Group-American College of Radiology Imaging Network E4512): a phase 3 trial. Lancet Respir Med. 2026 Nov; 14(11):972-982.